Abstract
The optimal dosing schedule of G-CSF for peripheral blood progenitor cell (PBPC) mobilization is still under investigation although many centers use 10 microg/kg/day in a single subcutaneous dose. However, G-CSF clearance increases with increasing absolute neutrophil count (ANC). Hence a G-CSF dosage adjusted to ANC might be a reasonable approach. We measured G-CSF trough serum levels by sandwich ELISA assay at different ANCs in eight patients undergoing treatment with filgrastim at 10 microg/kg/day in a single subcutaneous dose. A total of 26 samples were analyzed, and a strong correlation between increasing ANC and decreasing G-CSF levels was found by linear regression analysis (P < 0.0003, r2 = 0.4199). For ANC values above 5000/microl the trough serum levels, ie 24 h after administration, were consistently below the level that provides maximal clonogenic precursor stimulation in vitro (10 ng/ml). Serial serum G-CSF measurements performed in three patients at 0, 3, 6, 9 and 24 h after G-CSF administration, showed a reduction of the area under the curve (AUC) with increasing ANC. For an ANC of 20000/microl or greater, the G-CSF serum level fell under the maximal in vitro stimulation threshold of 10 ng/ml within 12 h. This pre...Continue Reading
Citations
Jan 17, 2004·Experimental Hematology·Arnon NaglerLydia Avivi
Apr 15, 2004·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Anne C Kotto-KomeDarlene A Calhoun
Jun 12, 1999·Journal of Immunological Methods·J GrangerM O'Reilly
Aug 23, 2001·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·G GürmanH Koç
Sep 19, 2006·Nature Medicine·Nilesh M DagiaRobert Sackstein
Dec 22, 1999·Transfusion·F LefrèreB Varet
Mar 10, 2001·Transfusion·C DosquetM Benbunan
Mar 5, 2005·European Journal of Endocrinology·Motoi SohmiyaYuzuru Kato
Jul 9, 2014·Proceedings of the National Academy of Sciences of the United States of America·Cristina I Silvescu, Robert Sackstein
Apr 25, 2007·Acta Oncologica·P Kellokumpu-LehtinenH Sintonen
Sep 2, 2014·Journal of Pharmaceutical Sciences·Xianxing XuYuanguo Cheng
Jul 25, 2003·American Journal of Hematology·Igor DolgopolovGeorge Mentkevich
Jan 24, 2003·Intensive Care Medicine·Kun YangChristophe Delclaux
Dec 16, 2010·Pharmaceutics·Rong Shi, Hartmut Derendorf
Dec 25, 2012·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Becky J NataliMichael Liebl
Jul 6, 2004·Oncogene·Wei-Shu WangYeu Su
Sep 28, 2002·Critical Care Medicine·Habiba L AttalahChristophe Delclaux